These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
675 related articles for article (PubMed ID: 30825207)
21. MicroRNA-655-3p functions as a tumor suppressor by regulating ADAM10 and β-catenin pathway in Hepatocellular Carcinoma. Wu G; Zheng K; Xia S; Wang Y; Meng X; Qin X; Cheng Y J Exp Clin Cancer Res; 2016 Jun; 35(1):89. PubMed ID: 27259866 [TBL] [Abstract][Full Text] [Related]
22. HOXA-AS2 Promotes Proliferation and Induces Epithelial-Mesenchymal Transition via the miR-520c-3p/GPC3 Axis in Hepatocellular Carcinoma. Zhang Y; Xu J; Zhang S; An J; Zhang J; Huang J; Jin Y Cell Physiol Biochem; 2018; 50(6):2124-2138. PubMed ID: 30415263 [TBL] [Abstract][Full Text] [Related]
23. Long non-coding RNA HCP5 functions as a sponge of miR-29b-3p and promotes cell growth and metastasis in hepatocellular carcinoma through upregulating DNMT3A. Zhou Y; Li K; Dai T; Wang H; Hua Z; Bian W; Wang H; Chen F; Ai X Aging (Albany NY); 2021 Jun; 13(12):16267-16286. PubMed ID: 34148029 [TBL] [Abstract][Full Text] [Related]
24. miR-654-3p predicts the prognosis of hepatocellular carcinoma and inhibits the proliferation, migration, and invasion of cancer cells. Yang J; Zhang Z; Chen S; Dou W; Xie R; Gao J Cancer Biomark; 2020; 28(1):73-79. PubMed ID: 32176631 [TBL] [Abstract][Full Text] [Related]
25. lncRNA A1BG-AS1 suppresses proliferation and invasion of hepatocellular carcinoma cells by targeting miR-216a-5p. Bai J; Yao B; Wang L; Sun L; Chen T; Liu R; Yin G; Xu Q; Yang W J Cell Biochem; 2019 Jun; 120(6):10310-10322. PubMed ID: 30556161 [TBL] [Abstract][Full Text] [Related]
26. Long Non-Coding RNA MALAT1 Regulates ZEB1 Expression by Sponging miR-143-3p and Promotes Hepatocellular Carcinoma Progression. Chen L; Yao H; Wang K; Liu X J Cell Biochem; 2017 Dec; 118(12):4836-4843. PubMed ID: 28543721 [TBL] [Abstract][Full Text] [Related]
27. Long non‑coding RNA MKLN1‑AS aggravates hepatocellular carcinoma progression by functioning as a molecular sponge for miR‑654‑3p, thereby promoting hepatoma‑derived growth factor expression. Gao W; Chen X; Chi W; Xue M Int J Mol Med; 2020 Nov; 46(5):1743-1754. PubMed ID: 33000222 [TBL] [Abstract][Full Text] [Related]
28. miR-1307-3p promotes tumor growth and metastasis of hepatocellular carcinoma by repressing DAB2 interacting protein. Chen S; Wang L; Yao B; Liu Q; Guo C Biomed Pharmacother; 2019 Sep; 117():109055. PubMed ID: 31176165 [TBL] [Abstract][Full Text] [Related]
29. LncRNA CRNDE promotes hepatocellular carcinoma progression by upregulating SIX1 through modulating miR-337-3p. Tang D; Zhao L; Peng C; Ran K; Mu R; Ao Y J Cell Biochem; 2019 Sep; 120(9):16128-16142. PubMed ID: 31099050 [TBL] [Abstract][Full Text] [Related]
30. LncRNA TMPO-AS1 promotes hepatocellular carcinoma cell proliferation, migration and invasion through sponging miR-329-3p to stimulate FOXK1-mediated AKT/mTOR signaling pathway. Guo X; Wang Y Cancer Med; 2020 Jul; 9(14):5235-5246. PubMed ID: 32462698 [TBL] [Abstract][Full Text] [Related]
31. A positive feedback loop involving the LINC00346/β-catenin/MYC axis promotes hepatocellular carcinoma development. Zhang N; Chen X Cell Oncol (Dordr); 2020 Feb; 43(1):137-153. PubMed ID: 31691159 [TBL] [Abstract][Full Text] [Related]
32. Long noncoding LINC01551 promotes hepatocellular carcinoma cell proliferation, migration, and invasion by acting as a competing endogenous RNA of microRNA-122-5p to regulate ADAM10 expression. Gao J; Yin X; Yu X; Dai C; Zhou F J Cell Biochem; 2019 Oct; 120(10):16393-16407. PubMed ID: 31270840 [TBL] [Abstract][Full Text] [Related]
33. LncRNA ST8SIA6-AS1 promotes hepatocellular carcinoma progression by regulating MAGEA3 and DCAF4L2 expression. Zhang X; Xu S; Hu C; Fang K; Zhou J; Guo Z; Zhu G; Li L Biochem Biophys Res Commun; 2020 Dec; 533(4):1039-1047. PubMed ID: 33012505 [TBL] [Abstract][Full Text] [Related]
34. lncRNA TUG1-Mediated Mir-142-3p Downregulation Contributes to Metastasis and the Epithelial-to-Mesenchymal Transition of Hepatocellular Carcinoma by Targeting ZEB1. He C; Liu Z; Jin L; Zhang F; Peng X; Xiao Y; Wang X; Lyu Q; Cai X Cell Physiol Biochem; 2018; 48(5):1928-1941. PubMed ID: 30092578 [TBL] [Abstract][Full Text] [Related]
35. Long non-coding RNA TPTEP1 exerts inhibitory effects on hepatocellular carcinoma by impairing microRNA-454-3p-mediated DLG5 downregulation. Dong Y; Wang Q; Sun J; Liu H; Wang H Dig Liver Dis; 2022 Feb; 54(2):268-279. PubMed ID: 34238665 [TBL] [Abstract][Full Text] [Related]
36. CircRNA circ-0038718 promotes hepatocellular carcinoma progression through sponging miR-139-3p. Sun R; Li H; Li J; Shen S; Cui G; Dong G Biochem Biophys Res Commun; 2020 Dec; 533(4):845-852. PubMed ID: 33008587 [TBL] [Abstract][Full Text] [Related]
37. MiR-542-3p inhibits metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by targeting UBE3C. Tao J; Liu Z; Wang Y; Wang L; Yao B; Li Q; Wang C; Tu K; Liu Q Biomed Pharmacother; 2017 Sep; 93():420-428. PubMed ID: 28666208 [TBL] [Abstract][Full Text] [Related]
38. LncRNA NORAD promotes proliferation, migration and angiogenesis of hepatocellular carcinoma cells through targeting miR-211-5p/FOXD1/VEGF-A axis. Sun DS; Guan CH; Wang WN; Hu ZT; Zhao YQ; Jiang XM Microvasc Res; 2021 Mar; 134():104120. PubMed ID: 33309645 [TBL] [Abstract][Full Text] [Related]
39. LncRNA DGCR5 represses the development of hepatocellular carcinoma by targeting the miR-346/KLF14 axis. Wang YG; Liu J; Shi M; Chen FX J Cell Physiol; 2018 Jan; 234(1):572-580. PubMed ID: 30216442 [TBL] [Abstract][Full Text] [Related]
40. Long noncoding RNA GIHCG promotes hepatocellular carcinoma progression through epigenetically regulating miR-200b/a/429. Sui CJ; Zhou YM; Shen WF; Dai BH; Lu JJ; Zhang MF; Yang JM J Mol Med (Berl); 2016 Nov; 94(11):1281-1296. PubMed ID: 27380494 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]